Context Therapeutics Inc

NEW
STU:6K9 (USA)  
€ 0.44 +0.028 (+6.86%) Aug 20
At Loss
P/B:
1.25
Market Cap:
€ 40.75M ($ 47.67M)
Enterprise V:
€ 4.13M ($ 4.84M)
Volume:
0
Avg Vol (2M):
8.27K
Trade In:

Context Therapeutics Inc (STU:6K9) Dividend

Context Therapeutics Inc (STU:6K9) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -79.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:6K9 Dividend

Does Context Therapeutics Inc (STU:6K9) pay a dividend?

Context Therapeutics Inc (STU:6K9) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Context Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Context Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -79.2% over the past 3 years.

What are dividend-paying alternatives to Context Therapeutics Inc?

For dividend-paying alternatives in Context Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.